help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camarillo, I. G.
Right arrow Articles by Talamantes, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camarillo, I. G.
Right arrow Articles by Talamantes, F.
Endocrinology Vol. 139, No. 8 3585-3589
Copyright © 1998 by The Endocrine Society

ARTICLES

Development of a Homologous Radioimmunoassay for Mouse Growth Hormone Receptor1

Ignacio G. Camarillo, Gudmundur Thordarson, Yonca N. Ilkbahar and Frank Talamantes

Department of Biology, University of California, Santa Cruz, California 95064

Address all correspondence and requests for reprints to: Dr. Frank Talamantes, Department of Biology, Sinsheimer Laboratories, University of California, Santa Cruz, California 95064. E-mail: PRL{at}aol.com

A RIA for mouse GH receptor (mGHR) was developed. A synthetic peptide corresponding to the carboxyl-terminal 14 amino acids of the mGHR (GHR-2 peptide) was used as the antigen for antiserum production. The synthetic peptide was also used as the standard and radioligand in the RIA. The ability of the antiserum to recognize the mGHR was demonstrated by quantitating receptor concentrations in liver and mammary gland from virgin and 15-day-pregnant mice. Serial dilutions of these samples yielded displacement curves parallel to the synthetic peptide. No significant cross-reactivity was seen with serum from virgin or 15-day-pregnant mice, mGH, recombinant mGH-binding protein (mGHBP), a synthetic peptide identical to the hydrophilic tail of mGHBP, or a 14-amino acid synthetic peptide corresponding to amino acids 338–351 of mGHR (GHR-1 peptide). The concentration range of the mGHR RIA was 0.5–200 nM, and the intra- and interassay coefficients of variation were 6.5% and 6.1%, respectively. The concentration of liver GHR increased significantly during pregnancy compared with that in virgin mice, from 0.246 ± 0.045 pmol/mg protein (mean ± SEM; n = 5) in the virgin animals to 1.015 ± 0.159 pmol/mg protein (n = 5) in pregnant mice. In contrast, the mGHR concentration in the mammary gland decreased significantly during pregnancy from 0.606 ± 0.201 pmol/mg protein (mean ± SEM; n = 5) to 0.299 ± 0.027 pmol/mg protein (n = 5). Comparison of the total number of binding sites in livers from virgin and pregnant mice using the GH RRA and the combined results of the mGHR and mGHBP RIAs showed that the two methods gave almost identical results for livers from virgin animals, or 0.363 ± 0.063 pmol/mg protein (mean ± SEM; n = 3) and 0.371 ± 0.008 pmol/mg protein (n = 3) for the GH RRA and the mGHR plus mGHBP RIAs, respectively. However, in livers from pregnant animals, the combined results from the mGHR and mGHBP RIAs were approximately 1.8 times higher than those obtained by the GH RRA, or 6.732 ± 0.612 pmol/mg protein (mean ± SEM; n = 3) and 3.693 ± 0.67 pmol/mg protein (n = 3) for the mGHR plus the mGHBP RIAs and the GH RRA, respectively. The increase in the total GH binding capacity in livers from pregnant mice compared with those from virgin animals was largely due to an increase in the GHBP content. The increase in GHR was only 2.4-fold, or from 0.153 ± 0.01 pmol/mg protein (mean ± SEM; n = 3) in virgin mice to 0.364 ± 0.03 pmol/mg protein (n = 3) in the 15-day-pregnant mice, whereas GHBP increased almost 30-fold during pregnancy, or from 0.218 ± 0.003 pmol/mg protein (mean ± SEM; n = 3) in virgin animals to 6.369 ± 0.607 pmol/mg protein (n = 3) in pregnant mice.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista
Negative Regulation of Growth Hormone Receptor Signaling
Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J G Miquet, A I Sotelo, F P Dominici, M S Bonkowski, A Bartke, and D Turyn
Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance
J. Endocrinol., December 1, 2005; 187(3): 387 - 397.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH
Endocrinology, June 1, 2004; 145(6): 2824 - 2832.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Fujikawa, H. Soya, K. L. K. Tamashiro, R. R. Sakai, B. S. McEwen, N. Nakai, M. Ogata, I. Suzuki, and K. Nakashima
Prolactin Prevents Acute Stress-Induced Hypocalcemia and Ulcerogenesis by Acting in the Brain of Rat
Endocrinology, April 1, 2004; 145(4): 2006 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
D. Cifone, F. P. Dominici, V. G. Pursel, and D. Turyn
Inability of heterologous growth hormone (GH) to regulate GH binding protein in GH-transgenic swine
J Anim Sci, July 1, 2002; 80(7): 1962 - 1969.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Gonzalez, J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Cytokine-Inducible SH2 Protein Up-Regulation Is Associated with Desensitization of GH Signaling in GHRH-Transgenic Mice
Endocrinology, February 1, 2002; 143(2): 386 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
X.-Q. Ding, R. V. Rao, S. M. Kuntz, E. L. Holicky, and L. J. Miller
Impaired Resensitization and Recycling of the Cholecystokinin Receptor by Co-expression of its Second Intracellular Loop
Mol. Pharmacol., April 13, 2001; 58(6): 1424 - 1433.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
B. Contreras and F. Talamantes
Growth Hormone (GH) and 17{beta}-Estradiol Regulation of the Expression of Mouse GH Receptor and GH-Binding Protein in Cultured Mouse Hepatocytes
Endocrinology, October 1, 1999; 140(10): 4725 - 4731.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
A. Edens and F. Talamantes
Alternative Processing of Growth Hormone Receptor Transcripts
Endocr. Rev., October 1, 1998; 19(5): 559 - 582.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. Lu, G. Schwartzbauer, M. A. Sperling, S. U. Devaskar, S. Thamotharan, P. D. Robbins, C. F. McTiernan, J.-L. Liu, J. Jiang, S. J. Frank, et al.
Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes
J. Biol. Chem., June 15, 2001; 276(25): 22892 - 22900.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society